Homozygous deletions and/or epigenetic silencing of PTPRD have also been identified in multiple human cancers, including glioblastoma, lung carcinoma and head and neck carcinoma [55], indicating that PTPRD is a tumor-suppressor gene [56, 57]. The gene discussed is PTPRD; the disease is cancer.